Who Paid My Doc
Asteghik Hacobian
Interventional Pain Medicine Barrington, NH Medical Doctor
NPI 1033184346 CMS profile 47182
944 Calef Hwy, Interventional Spine Medicine, Barrington, NH 03825
General payments
$995
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Asteghik Hacobian of Barrington, NH is reported in the CMS Open Payments database as having received $995 across 30 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 24th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $33 | 2 | |
| 2024 | General | $107 | 1 | |
| 2023 | General | $122 | 2 | |
| 2022 | General | $217 | 6 | |
| 2021 | General | $92 | 5 | |
| 2020 | General | $140 | 5 | |
| 2019 | General | $284 | 9 |
Beside peers
- Asteghik Hacobian
- Interventional Pain Medicine median
- Middle half of Interventional Pain Medicine
- National median
In program year 2025, general payments to Asteghik Hacobian were reported at $33. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.
Show as a table
| Year | Asteghik Hacobian | Interventional Pain Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $284 | $684 | $216–$2,079 | $163 |
| 2020 | $140 | $382 | $122–$1,109 | $114 |
| 2021 | $92 | $552 | $167–$1,554 | $132 |
| 2022 | $217 | $605 | $187–$1,924 | $149 |
| 2023 | $122 | $671 | $195–$1,915 | $160 |
| 2024 | $107 | $684 | $206–$1,837 | $164 |
| 2025 | $33 | $657 | $184–$1,753 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 8 drugsPart D claims
203
Drug cost
$1,724
Branded share of claims
17.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 22 | $551 | |
| Gabapentin | Generic | 62 | $365 | |
| Pregabalin | Generic | 15 | $235 | |
| Tramadol Hcl | Generic | 48 | $204 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 13 | $142 | |
| Cyclobenzaprine Hcl | Generic | 14 | $125 | |
| Oxycodone Hcl | Generic | 17 | $96 | |
| Diazepam | Generic | 12 | $6 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 37 billing codesPaid by Medicare
$153,352
Medicare patients
412
Services billed
2,763
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Depression | 27% | |
| Diabetes | 23% | |
| Ischemic heart disease | 22% | |
| Chronic kidney disease | 18% | |
| Atrial fibrillation | 17% | |
| COPD | 16% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, methylprednisolone acetate, 1 mg J1010 | Office | 15 | 680 | $69 |
| Injection, dexamethasone sodium phosphate, 1 mg J1100 | Office | 12 | 125 | $10 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
30 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Pain Medicine in New Hampshire
Anh Ngo
Interventional Pain Medicine · Newington, NH
Jan Slezak
Interventional Pain Medicine · Barrington, NH
Manuel Sanchez
Interventional Pain Medicine · Newington, NH
Allen Carignan
Interventional Pain Medicine · Barrington, NH
Susanna Pinson
Interventional Pain Medicine · Rye, NH
Janice Gellis
Interventional Pain Medicine · Lebanon, NH
Related records
Interventional Pain Medicine in New Hampshire
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Pain Medicine
Everyone recorded under this specialty, nationwide.
Doctors in New Hampshire
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.